A print friendly PDF version is available from this Communicable Diseases Intelligence issue's table of contents.
Table 3. Notification rates of diseases by state or territory, 1 April to 30 June 2004. (Rate per 100,000 population)
| Disease1 | State or territory
| Australia |
|||||||
|---|---|---|---|---|---|---|---|---|---|
ACT |
NSW |
NT |
Qld |
SA |
Tas |
Vic |
WA |
||
Bloodborne diseases |
|||||||||
| Hepatitis B (incident) | 2.5 |
1.0 |
4.0 |
1.4 |
0.5 |
8.4 |
0.7 |
1.0 |
1.2 |
| Hepatitis B (unspecified) | 14.9 |
79.2 |
NN |
22.8 |
17.3 |
25.2 |
31.5 |
17.8 |
43.1 |
| Hepatitis C (incident) | 3.7 |
0.2 |
NN |
NN |
2.1 |
1.7 |
1.1 |
3.7 |
1.2 |
| Hepatitis C (unspecified) | 71.9 |
72.9 |
145.2 |
74.7 |
47.7 |
142.5 |
58.2 |
56.3 |
68.4 |
| Hepatitis D | 0.0 |
0.1 |
0.0 |
0.5 |
0.0 |
0.0 |
0.1 |
0.0 |
0.2 |
Gastrointestinal diseases |
|||||||||
| Botulism | 0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
| Campylobacteriosis2 | 95.4 |
NN |
86.7 |
80.8 |
105.0 |
174.4 |
98.7 |
79.7 |
94.0 |
| Cryptosporidiosis | 0.0 |
3.6 |
54.4 |
22.7 |
4.5 |
5.0 |
6.7 |
6.4 |
8.8 |
| Haemolytic uraemic syndrome | 0.0 |
0.1 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.2 |
0.1 |
| Hepatitis A | 0.0 |
1.9 |
6.0 |
0.7 |
0.3 |
0.0 |
1.2 |
3.3 |
1.5 |
| Hepatitis E | 0.0 |
0.1 |
0.0 |
0.1 |
0.0 |
1.7 |
0.4 |
0.0 |
0.2 |
| Listeriosis | 0.0 |
0.7 |
0.0 |
0.3 |
0.3 |
0.0 |
0.2 |
0.2 |
0.4 |
| Salmonellosis (NEC) | 54.5 |
31.3 |
205.7 |
70.2 |
38.0 |
40.2 |
26.2 |
28.1 |
40.0 |
| Shigellosis | 1.2 |
1.2 |
72.6 |
2.4 |
3.9 |
1.7 |
1.2 |
6.4 |
2.9 |
| SLTEC, VTEC3 | 0.0 |
0.0 |
0.0 |
0.2 |
1.3 |
0.0 |
0.1 |
0.0 |
0.2 |
| Typhoid | 0.0 |
0.5 |
0.0 |
0.1 |
0.3 |
0.0 |
0.2 |
0.6 |
0.3 |
Quarantinable diseases |
|||||||||
| Cholera | 0.0 |
0.0 |
0.0 |
0.1 |
0.0 |
0.0 |
0.1 |
0.0 |
0.0 |
| Plague | 0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
| Rabies | 0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
| Smallpox | 0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
| Tularemia | 0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
| Viral haemorrhagic fever | 0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
| Yellow fever | 0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
Sexually transmissible diseases |
|||||||||
| Chlamydia | 194.5 |
139.3 |
893.4 |
225.0 |
174.4 |
216.3 |
152.2 |
214.9 |
179.3 |
| Donovanosis | 0.0 |
0.0 |
0.0 |
0.1 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
| Gonococcal infection | 7.4 |
19.1 |
893.4 |
33.5 |
32.2 |
13.4 |
21.0 |
82.0 |
37.9 |
| Syphilis (unspecified) | 6.2 |
0.0 |
114.9 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
1.2 |
| Syphilis < 2 years duration | 0.0 |
2.8 |
2.0 |
2.5 |
2.1 |
0.0 |
1.9 |
1.6 |
2.2 |
| Syphilis > 2 years or unknown duration | 0.0 |
13.2 |
34.3 |
3.5 |
0.3 |
0.0 |
7.1 |
5.5 |
7.8 |
| Syphilis - congenital | 0.0 |
0.0 |
4.0 |
0.0 |
0.0 |
0.0 |
0.1 |
0.0 |
0.1 |
Vaccine preventable diseases |
|||||||||
| Diphtheria | 0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
| Haemophilus influenzae type b | 0.0 |
0.1 |
2.0 |
0.1 |
0.0 |
0.0 |
0.0 |
0.0 |
0.1 |
| Influenza (laboratory confirmed) | 1.2 |
6.3 |
8.1 |
2.7 |
3.4 |
1.7 |
0.7 |
0.2 |
3.2 |
| Measles | 0.0 |
0.1 |
0.0 |
0.0 |
0.3 |
0.0 |
0.3 |
0.2 |
0.1 |
| Mumps | 0.0 |
0.7 |
0.0 |
0.5 |
0.3 |
0.0 |
0.0 |
0.0 |
0.4 |
| Pertussis | 16.1 |
34.3 |
2.0 |
14.7 |
15.5 |
6.7 |
9.1 |
30.1 |
21.2 |
| Pneumococcal disease (invassive) | 21.1 |
13.5 |
36.3 |
11.3 |
13.4 |
19.3 |
8.6 |
8.6 |
11.9 |
| Poliomyelitis | 0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
| Rubella | 0.0 |
0.4 |
0.0 |
0.4 |
0.0 |
0.0 |
0.0 |
0.0 |
0.2 |
| Rubella - congenital | 0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
| Tetanus | 0.0 |
0.0 |
0.0 |
0.1 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
Vectorborne diseases |
|||||||||
| Barmah Forest virus infection | 0.0 |
8.1 |
16.1 |
16.5 |
0.8 |
0.0 |
0.2 |
2.0 |
6.4 |
| Dengue | 2.5 |
0.4 |
10.1 |
5.0 |
0.0 |
0.0 |
0.2 |
0.2 |
1.3 |
| Flavivirus infection (NEC) | 0.0 |
0.2 |
0.0 |
2.5 |
0.0 |
0.0 |
0.1 |
0.0 |
0.6 |
| Japanese encephalitis | 0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
| Kunjin virus | 0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
| Malaria | 5.0 |
1.1 |
16.1 |
7.9 |
2.1 |
6.7 |
1.5 |
1.6 |
3.0 |
| Murray Valley encephalitis | 0.0 |
0.0 |
2.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
| Ross River virus infection | 3.7 |
19.4 |
34.3 |
91.2 |
1.8 |
8.4 |
1.7 |
28.3 |
27.9 |
Zoonoses |
|||||||||
| Anthrax | 0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
| Australian bat lyssavirus | 0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
| Brucellosis | 0.0 |
0.0 |
0.0 |
0.3 |
0.0 |
0.0 |
0.1 |
0.0 |
0.1 |
| Leptospirosis | 0.0 |
0.3 |
2.0 |
4.8 |
0.0 |
0.0 |
0.0 |
0.0 |
1.0 |
| Lyssavirus unspecified | 0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
| Ornithosis | 0.0 |
0.9 |
0.0 |
0.0 |
0.3 |
0.0 |
3.0 |
0.0 |
1.1 |
| Q fever | 0.0 |
3.1 |
2.0 |
3.6 |
1.6 |
0.0 |
0.9 |
0.4 |
2.1 |
Other bacterial infections |
|||||||||
| Legionellosis | 1.2 |
1.6 |
6.0 |
0.3 |
2.6 |
0.0 |
2.8 |
2.3 |
1.8 |
| Leprosy | 0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
| Meningococcal infection | 1.2 |
2.8 |
8.1 |
2.3 |
1.3 |
5.0 |
2.2 |
1.8 |
2.4 |
| Tuberculosis | 0.0 |
3.1 |
6.0 |
2.0 |
4.7 |
2.5 |
5.2 |
3.3 |
3.5 |
1. Rates are subject to retrospective revision.
2. Not reported from New South Wales where it is only notifiable as 'foodborne disease' or 'gastroenteritis in an institution'.
3. Infections with shiga-like toxin (verotoxin) producing Escherichia coli (SLTEC/VTEC).
NN Not notifiable.
NEC Not elsewhere classified.
This article was published in Communicable Diseases Intelligence Vol 28 No 3, September 2004.
CDI Search
Communicable Diseases Intelligence subscriptions
Sign-up to email updates: Subscribe Now
Communicable Diseases Surveillance
This issue - Vol 28 No 3, September 2004
Communicable Diseases Intelligence